Mutations in catalase-peroxidase KatG from isoniazid resistant Mycobacterium tuberculosis clinical isolates: insights from molecular dynamics simulations (original) (raw)
Significance of catalase-peroxidase (KatG) mutations in mediating isoniazid resistance in clinical strains of Mycobacterium tuberculosis
Nusrath Unissa
Journal of global antimicrobial resistance, 2018
View PDFchevron_right
Docking Simulations and QM/MM Studies between Isoniazid Prodrug, Catalase-Peroxidase (KatG) and S315T Mutant from Mycobacterium tuberculosis
Teodorico C. Ramalho
Computational and Mathematical Methods in Medicine, 2007
View PDFchevron_right
Theoretical insights on the binding of isoniazid to the active site residues of Mycobacterium tuberculosis catalase-peroxidase
gerardo janairo
Tuberculosis, 2018
View PDFchevron_right
Wild-type catalase peroxidase vs G279D mutant type: Molecular basis of Isoniazid drug resistance in Mycobacterium tuberculosis
Aishwarya Pratap Singh
Gene, 2018
View PDFchevron_right
Analysis of interactions of clinical mutants of catalase-peroxidase (KatG) responsible for isoniazid resistance in Mycobacterium tuberculosis with derivatives of isoniazid
Elizabeth Luke
Journal of global antimicrobial resistance, 2017
View PDFchevron_right
Mutation of katG in a clinical isolate of Mycobacterium tuberculosis: effects on catalase-peroxidase for isoniazid activation
Defi Natalia
The Ukrainian Biochemical Journal
View PDFchevron_right
In Silico Analysis Of Isoniazid Resistance In Mycobacterium Tuberculosis
Nusrath Unissa
2014
View PDFchevron_right
Crystal Structure of Mycobacterium tuberculosis Catalase-Peroxidase
Nigel Eady
Journal of Biological Chemistry, 2004
View PDFchevron_right
Molecular Dynamics Simulation Studies of the Wild-Type, I21V, and I16T Mutants of Isoniazid-Resistant Mycobacterium tuberculosis Enoyl Reductase (InhA) in Complex with NADH: Toward the Understanding of NADH-InhA Different Affinities
Osmar Norberto de Souza
Biophysical Journal, 2005
View PDFchevron_right
Activity loss by H46A mutation in Mycobacterium tuberculosis isocitrate lyase is due to decrease in structural plasticity and collective motions of the active site
Timir Tripathi
View PDFchevron_right
Recombinant Mycobacterium tuberculosis KatG(S315T) Is a Competent Catalase‐Peroxidase with Reduced Activity toward Isoniazid
Stephen Naylor
The Journal of Infectious Diseases, 1997
View PDFchevron_right
The Tuberculosis Prodrug Isoniazid Bound to Activating Peroxidases
Isabel Macdonald
Journal of Biological Chemistry, 2007
View PDFchevron_right
Molecular Dynamics Investigation of the Role of Residues D137 and S315 to INH Binding in KatG
Matt Bawn
2018
View PDFchevron_right
Insights Into Mutations Induced Conformational Changes and Rearrangement of Fe2+ Ion in pncA Gene of Mycobacterium tuberculosis to Decipher the Mechanism of Resistance to Pyrazinamide
Maryam Arshad
Frontiers in Molecular Biosciences, 2021
View PDFchevron_right
Active site structure of the catalase-peroxidases from Mycobacterium tuberculosis and Escherichia coli by extended X-ray absorption fine structure analysis
Linda Powers
Biochimica Et Biophysica Acta-protein Structure and Molecular Enzymology, 2001
View PDFchevron_right
Molecular dynamics of Mycobacterium tuberculosis KasA: implications for inhibitor and substrate binding and consequences for drug design
Caroline Kisker
Journal of Computer-Aided Molecular Design, 2011
View PDFchevron_right
Impact of Distal Side Water and Residue 315 on Ligand Binding to Ferric Mycobacterium tuberculosis Catalase−Peroxidase (KatG) †
Richard Magliozzo
Biochemistry, 2008
View PDFchevron_right
Structural insights of catalytic mechanism in mutant pyrazinamidase of Mycobacterium tuberculosis
Dong-Qing Wei
View PDFchevron_right
Detection of novel coupled mutations in the katG gene (His276Met, Gln295His and Ser315Thr) in a multidrug-resistant Mycobacterium tuberculosis strain from Chennai, India, and insight into the molecular mechanism of isoniazid resistance using structural bioinformatics approaches
Parvathy Rajan
International Journal of Antimicrobial Agents, 2011
View PDFchevron_right
Application of Computational Methods in Understanding Mutations in Mycobacterium tuberculosis Drug Resistance
Albert Zindoga
Frontiers in Molecular Biosciences, 2021
View PDFchevron_right
Structural and quantum mechanical computations to elucidate the altered binding mechanism of metal and drug with pyrazinamidase from Mycobacterium tuberculosis due to mutagenicity
Saima Iftikhar
Journal of molecular graphics & modelling, 2018
View PDFchevron_right
Alterations in conformational topology and interaction dynamics caused by L418A mutation leads to activity loss of Mycobacterium tuberculosis isocitrate lyase
Amit Sonkar
Biochemical and biophysical research communications, 2017
View PDFchevron_right
Molecular dynamics simulations of a set of isoniazid derivatives bound to InhA, the enoyl-acp reductase from M. tuberculosis
Kerly Pasqualoto
International Journal of Quantum Chemistry, 2006
View PDFchevron_right
Antibiotic Resistance in Mycobacterium tuberculosis
Kalina Ranguelova
Journal of Biological Chemistry, 2009
View PDFchevron_right
Theoretical Study of the Interactions Involved in the Inhibition of Mycobacterium Tuberculosis Methionine Aminopeptidase by Several Molecules
Hanane Boucherit
Computational Biology and Bioinformatics, 2014
View PDFchevron_right
Using cryo-EM to understand antimycobacterial resistance in the catalase-peroxidase (KatG) from Mycobacterium tuberculosis
Tom Blundell
Structure, 2021
View PDFchevron_right